gala-peptide and 1-2-dielaidoylphosphatidylethanolamine

gala-peptide has been researched along with 1-2-dielaidoylphosphatidylethanolamine* in 2 studies

Other Studies

2 other study(ies) available for gala-peptide and 1-2-dielaidoylphosphatidylethanolamine

ArticleYear
Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes.
    The journal of gene medicine, 2005, Volume: 7, Issue:11

    One of the critical steps in intracellular gene delivery using cationic liposomes is the endosomal escape of the plasmid/liposome complexes to the cytosol. The addition of GALA, a pH-sensitive fusogenic peptide, is a promising method to accelerate this step in order to enhance the expression of the desired proteins. Detailed studies on the methods of enhancement would broaden the horizon of its application.. Using representative commercially available cationic liposomes (Lipofectin, Lipofectamine, and Lipofectamine 2000), the effects of GALA on transfection efficiency were studied by luciferase assay and confocal microscopic observations.. A concentration-dependent increase in the transfection efficiency was observed for GALA. Addition of 0.1 microM GALA to the plasmid/liposome complex significantly increased the transfection efficiency, especially in the case of Lipofectin, but higher concentration of GALA decreased transfection efficiency. Successful reduction in the liposomal dosage was attained by employing GALA while maintaining a high transfection efficiency. Interestingly, although the transfection efficiency was higher in the presence of GALA, a lower amount of the plasmid DNA was taken up by the cells. Confocal microscopic observations of the rhodamine-labeled plasmid did not show a significant difference in the cellular localization among cells incubated in the presence or absence of GALA, suggesting that a slight increase in GALA-induced release of the plasmid to the cytosol may cause a significant change in the transfection efficiency.. The unique features of GALA to mediate improved transfection efficiencies were identified.

    Topics: Animals; Chlorocebus aethiops; COS Cells; Drug Carriers; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Lipids; Liposomes; PC12 Cells; Peptides; Phosphatidylethanolamines; Plasmids; Rats; Transfection

2005
Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum.
    Biochimica et biophysica acta, 2000, Feb-15, Volume: 1463, Issue:2

    Cationic liposome-DNA complexes ('lipoplexes') are used as gene delivery vehicles and may overcome some of the limitations of viral vectors for gene therapy applications. The interaction of highly positively charged lipoplexes with biological macromolecules in blood and tissues is one of the drawbacks of this system. We examined whether coating cationic liposomes with human serum albumin (HSA) could generate complexes that maintained transfection activity. The association of HSA with liposomes composed of 1, 2-dioleoyl-3-(trimethylammonium) propane and dioleoylphosphatidylethanolamine, and subsequent complexation with the plasmid pCMVluc greatly increased luciferase expression in epithelial and lymphocytic cell lines above that obtained with plain lipoplexes. The percentage of cells transfected also increased by an order of magnitude. The zeta potential of the ternary complexes was lower than that of the lipoplexes. Transfection activity by HSA-lipoplexes was not inhibited by up to 30% serum. The combined use of HSA and a pH-sensitive peptide resulted in significant gene expression in human primary macrophages. HSA-lipoplexes mediated significantly higher gene expression than plain lipoplexes or naked DNA in the lungs and spleen of mice. Our results indicate that negatively charged HSA-lipoplexes can facilitate efficient transfection of cultured cells, and that they may overcome some of the problems associated with the use of highly positively charged complexes for gene delivery in vivo.

    Topics: Amino Acid Sequence; Animals; B-Lymphocytes; Blood; Cell Line; COS Cells; Drug Carriers; Fatty Acids, Monounsaturated; HeLa Cells; Humans; Liposomes; Luciferases; Mice; Molecular Sequence Data; Peptides; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Serum Albumin; Transfection

2000